Xcout IntelLipomedix
Lipomedix Pharmaceuticals Ltd. is a clinical-stage, oncology-focused pharmaceutical company developing cancer therapies based on liposome delivery technology. The company advances its drug pipeline through clinical trials, including Phase 1b and Phase 2A studies evaluated in medical centers in Israel.
Subscribe to see Lipomedix’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Lipomedix at a glance
Lipomedix is a biomedical company headquartered in Israel. Xcout tracks 7 named people at Lipomedix, including Eliyahu Shalom (Chief Executive Officer of Lipomedix).
Lipomedix leadership
- Eliyahu ShalomChief Executive Officer of Lipomedix
- William ConklingPresident of Rafael Holdings
- John GoldbergChief Medical Officer of Rafael Holdings
- Howard JonasChairman of the Board of Directors
- Alberto Gabizonfounder and Chief Scientific Advisor
- Rami Kremienco-founder of Lipomedix
1 more named person on record for Lipomedix, with roles, board committees and tenure — see the full roster →
Lipomedix competitors
A few of Lipomedix's closest competitors — see the full list of competitors and alternatives →
LipoCure is an Israel-based private biomedical company that specializes in the development of therapeutics utilizing proprietary liposome-based nano-drugs. The company focuses on technologies featuring novel drug-loading and controlled drug-release mechanisms.
Ayana Pharma Ltd is an Israeli pharmaceutical company based in Jerusalem and Yavne that focuses on the development and manufacturing of liposomal therapeutics and lipid-based treatments for cancer and other conditions. The company specializes in leveraging the clinical profile of anticancer drugs such as Doxil.
Cellyrix Therapeutics is an Israeli biotechnology company that develops targeted cancer therapies by leveraging single-cell RNA sequencing and artificial intelligence. The firm operates as an oncology-focused drug discovery venture headquartered in Rehovot, Israel.
Longevitix Ltd. develops advanced technology focused on democratizing longevity medicine within the healthcare sector. Headquartered in Tel Aviv, Israel, the company operates in the longevity tech space with a compact team dedicated to expanding access to specialized life-extension medical solutions.
Mana.bio is an AI-based drug delivery startup headquartered in Tel Aviv, Israel, focusing on gene therapy and lipid nanoparticle development for mRNA and oligonucleotide therapeutics. The company leverages artificial intelligence to create advanced platforms for next-generation vaccines and genetic medicines.
OncoMyx Therapeutics, Inc. is a biotechnology company headquartered in Phoenix, Arizona, that develops innovative oncolytic immunotherapies to target and destroy tumors.
Get Lipomedix's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Lipomedix in Xcout Intel
- 7 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access